Tuck David 4
4 · CURIS INC · Filed May 17, 2018
Insider Transaction Report
Form 4
CURIS INCCRIS
Tuck David
Chief Medical Officer
Transactions
- Award
Employee stock option (right to buy)
2018-05-15+535,000→ 535,000 totalExercise: $0.69Exp: 2028-01-21→ Common stock (535,000 underlying)
Footnotes (1)
- [F1]This option grant, as disclosed in Curis Inc.'s 2018 proxy statement, was approved by the Compensation Committee of the Board of Directors of Curis, Inc. on January 22, 2018, contingent upon shareholder approval of Curis's Third Amended and Restated 2010 Stock Incentive Plan to increase the number of shares authorized for issuance thereunder; and further provided that such option would not be exercisable and no common stock would be issued thereunder, if the Third Amended and Restated 2010 Plan was not approved by Curis's shareholders. On May 15, 2018, at the 2018 annual meeting of shareholders, Curis's shareholders approved the Third Amended and Restated 2010 Plan. The option grant described in this Form 4 filing vests as to 25% of the original shares on January 22, 2019 and as to an additional 6.25% of the original shares each successive quarter and until January 22, 2022.